The approval broadens VEXIM’s potential market.
VEXIM is a medical device company focusing on the minimally invasive treatment of traumatic spinal pathologies.
More Articles on Devices:
New Developments in Knee Technology: ATTUNE® Rotating Platform & Anatomic Patella From DePuy Synthes Joint Reconstruction
Pain Management Devices Market in the U.S. to Reach Nearly $2.7B by 2022
Baxano Surgical Receives FDA 510(k) Clearance for Avance MIS Pedicle Screw System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
